Leveraging real-world evidence for comparative efficacy: Delayed-release dimethyl fumarate vs Fingolimod and glatiramer acetate in relapsing remittin MS

Document Type

Presentation

Publication Date

2018

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences

This document is currently not available here.

Share

COinS